文献速递消化道肿瘤与早癌消化内镜

家族性腺瘤性息肉病患者十二指肠乳头活检的风险、获益及对管理的影响

Risks, Benefits, and Effects on Management for Biopsy of the Papilla in Patients With Familial Adenomatous Polyposis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-05-31

该单中心研究纳入2011年至2018年273例家族性腺瘤性息肉病(FAP)患者,共792次食管胃十二指肠镜(EGD)行乳头活检。活检后胰腺炎发生率为0.73%(2例)。纳入活检组织学数据使36例(13.2%)患者Spigelman分期(SS)升高,其中3.3%需考虑预防性十二指肠切除术。结论认为乳头活检后胰腺炎罕见,活检组织学可改变SS并影响患者管理。

要点

  • FAP患者乳头活检后胰腺炎发生率为0.73%(2例),属罕见并发症。
  • 纳入活检组织学数据使13.2%(36例)患者SS升高。
  • SS升高后3.3%患者需考虑预防性十二指肠切除术。

核心结论

  • FAP患者十二指肠乳头活检后胰腺炎罕见。
  • 乳头活检组织学数据可改变SS并影响患者管理。

研究设计与样本

  • 单中心连续纳入2011年1月至2018年12月FAP患者,要求至少1次EGD行乳头活检,排除上消化道手术史者。
  • 共273例FAP患者,792次EGD行乳头活检,每例患者接受1至8次独立活检检查。
  • 收集人口学、内镜及组织学数据,计算纳入与不纳入活检结果的SS,术后胰腺炎定义为EGD后7天内腹痛、脂肪酶水平达正常上限3倍或影像学符合胰腺炎中2项。

主要发现

  • 273例患者中2例(0.73%)发生胰腺炎,1例发生于外观正常乳头活检后,1例发生于外观异常乳头活检后。
  • 纳入活检数据使36例(13.2%)患者SS升高。
  • SS升高后,3.3%患者需考虑预防性十二指肠切除术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Ampullary and duodenal cancer are the leading causes of death in patients with familial adenomatous polyposis (FAP) after colectomy has been performed. Risk of duodenal cancer is determined based on Spigelman stage (SS) of duodenal polyposis. Guidelines recommend endoscopic surveillance of the duodenum and visualization of the papilla to stage duodenal polyposis. There is no consensus on whether biopsies should be routinely collected from duodenal papilla and findings included in SS. Additionally, there are no data on the risk of pancreatitis after biopsy collection from papilla of patients with FAP. We studied the incidence of pancreatitis after biopsy of the papilla in patients with FAP and effects of biopsy findings on SS. METHODS: We identified consecutive patients with FAP at a single center from January 2011 through December 2018 with ≥1 endoscopy with biopsy of the papilla. Patients with history of foregut surgery were excluded. We identified 273 patients with FAP who had biopsies collected from papilla over 792 EGDs, with 1-8 independent exams with biopsy per patient. We collected demographic, endoscopic, and histology data from patients and calculated SS with vs without biopsy findings. Post-procedural pancreatitis was defined by 2 of the following: abdominal pain, lipase level 3-fold the upper limit of normal, or radiography findings consistent with pancreatitis within 7 days of esophagogastroduodenoscopy (EGD). RESULTS: Pancreatitis developed in 2 patients (0.73%): 1 after biopsy of a normal-appearing papilla and 1 after biopsy of an abnormal appearing papilla. Inclusions of biopsy data increased SS in 36 patients (13.2%), with consideration of prophylactic duodenectomy for 3.3%. CONCLUSIONS: Pancreatitis after biopsy of the duodenal papilla is rare. Histology data obtained from biopsy of the papilla in patients with FAP can change SS and affect patient management.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Mehta NA, Shah RS, Yoon J, et al. Risks, Benefits, and Effects on Management for Biopsy of the Papilla in Patients With Familial Adenomatous Polyposis. Clin Gastroenterol Hepatol. 2020. PMID: 32492482. doi:10.1016/j.cgh.2020.05.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。